ORGO

Organogenesis Holdings Stock Analysis

AI Rating

Low
  • Quality6/10
  • Growth↓ 0/10
  • Momentum↓ 4/10
Organogenesis Holdings sales and earnings growth
ORGO Growth
Low
  • Revenue Y/Y↓ 2.24%
  • EPS Y/Y↓ -100.00%
  • FCF Y/Y↓ -1427.81%
Organogenesis Holdings gross and profit margin trends
ORGO Profitability
Neutral
  • Gross margin ↑ 74.50%
  • EPS margin↓ -2.90%
  • ROIC↓ -2.60%
Organogenesis Holdings net debt vs free cash flow
ORGO Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -3.9

Organogenesis Holdings stock volatility is higher than the overall market. We give it a Great risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗